Lataa...
Familial Hypercholesterolemia and Lipoprotein Apheresis
Lipoprotein apheresis has been developed as the treatment for refractory familial hypercholesterolemia (FH) to remove low-density lipoprotein (LDL), which is the main pathogenic factor. Currently, three procedures are available in Japan, including the plasma exchange, double-membrane filtration, and...
Tallennettuna:
| Julkaisussa: | J Atheroscler Thromb |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Japan Atherosclerosis Society
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6711846/ https://ncbi.nlm.nih.gov/pubmed/31231083 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.RV17033 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|